These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25109569)

  • 21. 6beta-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice.
    Yancey-Wrona JE; Raymond TJ; Mercer HK; Sadée W; Bilsky EJ
    Life Sci; 2009 Sep; 85(11-12):413-20. PubMed ID: 19583969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diverse clinical uses of opioid receptor drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 May; 48(5):11-4. PubMed ID: 20415289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Codeine-induced hyperalgesia and allodynia: investigating the role of glial activation.
    Johnson JL; Rolan PE; Johnson ME; Bobrovskaya L; Williams DB; Johnson K; Tuke J; Hutchinson MR
    Transl Psychiatry; 2014 Nov; 4(11):e482. PubMed ID: 25386959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naloxone blocks endomorphin-1 but not endomorphin-2 induced inhibition of tachykinergic contractions of guinea-pig isolated bronchus.
    Fischer A; Undem BJ
    Br J Pharmacol; 1999 Jun; 127(3):605-8. PubMed ID: 10401549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.
    McLane VD; Bergquist I; Cormier J; Barlow DJ; Houseknecht KL; Bilsky EJ; Cao L
    Life Sci; 2017 Sep; 185():1-7. PubMed ID: 28723417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the opioid system in incentive downshift situations.
    Daniel AM; Ortega LA; Papini MR
    Neurobiol Learn Mem; 2009 Oct; 92(3):439-50. PubMed ID: 19531382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphine amplifies mechanical allodynia via TLR4 in a rat model of spinal cord injury.
    Ellis A; Grace PM; Wieseler J; Favret J; Springer K; Skarda B; Ayala M; Hutchinson MR; Falci S; Rice KC; Maier SF; Watkins LR
    Brain Behav Immun; 2016 Nov; 58():348-356. PubMed ID: 27519154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4.
    Li Y; Adamek P; Zhang H; Tatsui CE; Rhines LD; Mrozkova P; Li Q; Kosturakis AK; Cassidy RM; Harrison DS; Cata JP; Sapire K; Zhang H; Kennamer-Chapman RM; Jawad AB; Ghetti A; Yan J; Palecek J; Dougherty PM
    J Neurosci; 2015 Sep; 35(39):13487-500. PubMed ID: 26424893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid system contribution to the antidepressant-like action of m-trifluoromethyl-diphenyl diselenide in mice: A compound devoid of tolerance and withdrawal syndrome.
    Rosa SG; Pesarico AP; Tagliapietra CF; da Luz SC; Nogueira CW
    J Psychopharmacol; 2017 Sep; 31(9):1250-1262. PubMed ID: 28857657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of opioid compounds on feeding and activity of the cockroach, Periplaneta americana.
    Cooper PD; Dennis SR; Woodman JD; Cowlings A; Donnelly C
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Apr; 151(3):298-302. PubMed ID: 20005975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
    Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
    J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
    Picker MJ
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of naloxone on ischemic acute kidney injury in the mouse.
    Mutoh J; Ohsawa M; Hisa H
    Neuropharmacology; 2013 Aug; 71():10-8. PubMed ID: 23523991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC; Purohit V; Patel K; Zhang Q
    Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of μ- and δ-opioid receptor function in the rewarding effect of (±)-pentazocine.
    Mori T; Itoh T; Yoshizawa K; Ise Y; Mizuo K; Saeki T; Komiya S; Masukawa D; Shibasaki M; Suzuki T
    Addict Biol; 2015 Jul; 20(4):724-32. PubMed ID: 25065832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2001 Jul; 298(1):156-64. PubMed ID: 11408537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology.
    Zádor F; Király K; Váradi A; Balogh M; Fehér Á; Kocsis D; Erdei AI; Lackó E; Zádori ZS; Hosztafi S; Noszál B; Riba P; Benyhe S; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2017 Aug; 809():111-121. PubMed ID: 28502630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.